|
药明生物技术有限公司, 02269.HK - 综合现金流量表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
经营活动之现金流量 |
6,127,335 |
3,781,244 |
1,975,514 |
1,286,080 |
813,710 |
403,615 |
129,382 |
107,150 |
21,505 |
投资回报及融资费用之现金流量 |
11,540 |
-15,208 |
-3,909 |
3,817 |
79,755 |
-33,619 |
-30,399 |
-20,590 |
-2,556 |
已收利息 |
112,593 |
67,992 |
78,635 |
53,618 |
79,755 |
3,149 |
0 |
0 |
0 |
已付利息 |
-108,239 |
-83,200 |
-82,544 |
-49,801 |
0 |
-36,768 |
-30,399 |
-2,531 |
-2,556 |
已收股息 |
8,315 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
已付股息 |
-1,129 |
0 |
0 |
0 |
0 |
0 |
0 |
-18,059 |
0 |
其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
退回/(已缴)税项 |
-585,662 |
-349,986 |
-94,238 |
-78,001 |
-52,103 |
-43,335 |
-47,461 |
0 |
0 |
投资活动之现金流量 |
-6,028,031 |
-9,669,662 |
-7,294,918 |
-4,547,548 |
-495,829 |
-2,216,400 |
-421,144 |
-336,216 |
-50,120 |
增添固定资产 |
-5,868,390 |
-6,523,114 |
-6,024,780 |
-3,233,464 |
-1,340,586 |
-670,601 |
-428,883 |
-334,362 |
-51,044 |
出售固定资产 |
20,125 |
80,856 |
66,485 |
47,645 |
530 |
50 |
0 |
66 |
46 |
投资增加 |
-10,098,514 |
-60,671,006 |
-18,028,821 |
-4,777,430 |
-1,057,205 |
-1,909,886 |
0 |
0 |
0 |
投资减少 |
8,937,049 |
56,982,317 |
18,172,289 |
3,748,613 |
1,444,708 |
1,275,430 |
0 |
0 |
0 |
与关联人士之现金流量 |
579,939 |
0 |
216,892 |
0 |
600 |
-278,083 |
-541,838 |
402,398 |
32,992 |
其他 |
401,760 |
461,285 |
-1,696,983 |
-332,912 |
456,124 |
-633,310 |
549,577 |
-404,318 |
-32,114 |
融资活动前之现金流量 |
-474,818 |
-6,253,612 |
-5,417,551 |
-3,335,652 |
345,533 |
-1,889,739 |
-369,622 |
-249,656 |
-31,171 |
融资活动之现金流量 |
-2,483,353 |
8,292,659 |
6,648,188 |
5,462,624 |
3,206,824 |
2,266,075 |
363,162 |
397,990 |
32,992 |
新增贷款 |
2,389,197 |
675,284 |
1,171,239 |
2,049,825 |
0 |
346,585 |
918,000 |
0 |
4,424 |
偿还贷款 |
-2,684,215 |
-822,110 |
-349,859 |
-162,174 |
0 |
-1,238,616 |
-13,000 |
-4,408 |
-4,424 |
定息/债项工具融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
偿还定息/债项工具 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
股本融资 |
36,180 |
10,956,600 |
5,609,916 |
3,574,973 |
3,206,224 |
3,436,189 |
0 |
0 |
0 |
与关联人士之现金流量 |
579,939 |
0 |
216,892 |
0 |
600 |
-278,083 |
-541,838 |
402,398 |
32,992 |
其他 |
-2,804,454 |
-2,517,115 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
现金及等同现金之增加/(减少) |
-2,958,171 |
2,039,047 |
1,230,637 |
2,126,972 |
3,552,357 |
376,336 |
-6,460 |
148,334 |
1,821 |
年初之现金及现金等同项目 |
9,003,280 |
7,095,735 |
6,205,496 |
4,084,395 |
503,881 |
169,102 |
158,229 |
5,948 |
4,176 |
外汇兑换率变动之影响/(其他) |
350,113 |
-131,502 |
-340,398 |
-5,871 |
28,157 |
-41,557 |
17,333 |
3,947 |
-49 |
年终之现金及现金等同项目 |
6,395,222 |
9,003,280 |
7,095,735 |
6,205,496 |
4,084,395 |
503,881 |
169,102 |
158,229 |
5,948 |
货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
单位 |
核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|